BCM
RKDA icon

Bayesian Capital Management’s Arcadia Biosciences RKDA Stock Holding History

Bayesian Capital Management’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-903
Closed -$99K – 613
2021
Q1 		$99K Buy
+903
New +$111K 0.02% 494

Other funds holding RKDA

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bayesian Capital Management's RKDA Position: Q2 2021 in Review

Bayesian Capital Management sold out of Arcadia Biosciences (RKDA) in Q2 2021, closing a stake of 903 shares — an estimated $99K sold.

Bayesian Capital Management first reported a position in RKDA in Q1 2021 and held it in 1 quarter. The position peaked at $99K in Q1 2021. 27 funds tracked by Wall St. Rank hold RKDA as of Q2 2021.

  • Bayesian Capital Management reported no remaining Arcadia Biosciences position as of Q2 2021 after selling out during the quarter.
  • Bayesian Capital Management sold 903 Arcadia Biosciences shares in Q2 2021, an estimated $99K.
  • Bayesian Capital Management first reported a position in Arcadia Biosciences in Q1 2021 and held it in 1 quarter.
  • Bayesian Capital Management's Arcadia Biosciences position peaked at $99K in Q1 2021.
  • 27 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2021.

Based on Bayesian Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.